|
AU2005201115A1
|
|
Quinones for treatment of diseases
|
|
AU2003231670A1
|
|
Methods for modulating macrophage proliferation using polyamine analogs
|
|
US2004192665A1
|
|
Conjugates of porphyrin compounds with chemotherapeutic agents
|
|
EP1453787A1
|
|
Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
|
|
EP1444520A2
|
|
Methods for monitoring amyotrophic lateral sclerosis
|
|
IL161428D0
|
|
Oligoamine derivatives, methods for the production thereof and pharmaceutical compositions containing the same
|
|
AU3512602A
|
|
Novel polyamine analog-amino acid conjugates useful as anticancer agents
|
|
CA2417064A1
|
|
Cyclic polyamine compounds for cancer therapy
|
|
US6482943B1
|
|
Quinones as disease therapies
|
|
CA2372611A1
|
|
Quinones for treatment of diseases
|
|
CA2368801A1
|
|
Conjugates as therapies for cancer and prostate diseases
|
|
US6649587B1
|
|
Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
|
|
EP1574507A2
|
|
Furo- and pyrano-naphthoquinones and their use in the treatment of cancer
|
|
AU4679900A
|
|
Conformationally restricted polyamine analogs as disease therapies
|
